Theoretically it seems highly unlikely that relatively small peptides could mimic functionally discontinuous epitopes of antigens. Nevertheless various recent reports show this to be the case. Peptide mimics of protein-, polysaccharide- and DNA-epitopes have been shown to be able to replace the native epitope. Moreover, some of them are able to induce, when used in a vaccine, antibodies with the same activity as that of the antibody used as a template. These mimics, called mimotopes, can be used in vaccines and diagnostics and can be developed more or less systematically using solely antibodies and random, semi-random and dedicated peptide arrays or libraries. Furthermore, the mimotope concept which seems to have proven itself for antibody ...
Random peptide libraries (RFL) displayed on phage are being increasingly used to identify mimics of ...
One of the most pressing global issues in human health today includes the need to develop new, safer...
A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and ...
Theoretically it seems highly unlikely that relatively small peptides could mimic functionally disco...
Antigen recognition by antibodies or ligand-receptor interactions involve small areas of the molecul...
Mechanisms of broad cross-protection, as seen in viral infection and also applied to vaccines, empha...
Antigen-mimicking peptide (mimotope)-based vaccines are one of the most promising forms of active-im...
We describe the use of random peptide sequences for the mapping of antigenic determinants. An oligon...
A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and ...
Aims: To identify peptides that mimic (mimotopes) conformational and protective epitopes of RSV fusi...
AbstractSynthetic peptides mimicking a conformational B-cell epitope (M2) of the measles virus fusio...
Vaccines based on peptide mimics (mimotopes) of conformational tumor antigen epitopes have been inve...
<div><p>A major hurdle in vaccine development is the difficulty in identifying relevant target epito...
Peptide mimotopes of tumor antigen epitopes have been proposed as components of tumor vaccines. In t...
Macromolecular structures represent an interesting starting point for the design and synthesis of sm...
Random peptide libraries (RFL) displayed on phage are being increasingly used to identify mimics of ...
One of the most pressing global issues in human health today includes the need to develop new, safer...
A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and ...
Theoretically it seems highly unlikely that relatively small peptides could mimic functionally disco...
Antigen recognition by antibodies or ligand-receptor interactions involve small areas of the molecul...
Mechanisms of broad cross-protection, as seen in viral infection and also applied to vaccines, empha...
Antigen-mimicking peptide (mimotope)-based vaccines are one of the most promising forms of active-im...
We describe the use of random peptide sequences for the mapping of antigenic determinants. An oligon...
A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and ...
Aims: To identify peptides that mimic (mimotopes) conformational and protective epitopes of RSV fusi...
AbstractSynthetic peptides mimicking a conformational B-cell epitope (M2) of the measles virus fusio...
Vaccines based on peptide mimics (mimotopes) of conformational tumor antigen epitopes have been inve...
<div><p>A major hurdle in vaccine development is the difficulty in identifying relevant target epito...
Peptide mimotopes of tumor antigen epitopes have been proposed as components of tumor vaccines. In t...
Macromolecular structures represent an interesting starting point for the design and synthesis of sm...
Random peptide libraries (RFL) displayed on phage are being increasingly used to identify mimics of ...
One of the most pressing global issues in human health today includes the need to develop new, safer...
A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and ...